Fate Therapeutics (FATE)
(Real Time Quote from BATS)
$3.06 USD
+0.01 (0.33%)
Updated Oct 8, 2024 02:38 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Earnings News For FATE
-
Why Is Fate Therapeutics (FATE) Up 18.7% Since Last Earnings Report?
-
Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates
-
Fate Therapeutics: Q2 Earnings Snapshot
-
Fate Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
-
Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
-
Fate Therapeutics: Q1 Earnings Snapshot
-
Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
-
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?
-
Fate Therapeutics (FATE) Q4 Earnings Beat, Revenues Fall Y/Y
-
Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
-
Fate Therapeutics: Q4 Earnings Snapshot
-
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
-
Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Fate Therapeutics (FATE) Up 10.3% Since Last Earnings Report: Can It Continue?
-
Fate Therapeutics: Q3 Earnings Snapshot
-
Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
-
Why Is Fate Therapeutics (FATE) Down 23.5% Since Last Earnings Report?
-
Fate Therapeutics (FATE) Reports Q2 Loss, Lags Revenue Estimates
-
Fate Therapeutics: Q2 Earnings Snapshot
-
Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
-
Fate Therapeutics (FATE) Down 17.8% Since Last Earnings Report: Can It Rebound?
-
Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
-
Fate Therapeutics: Q1 Earnings Snapshot
-
Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates
-
Fate Therapeutics (FATE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release